Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Knee Surgery, Sports Traumatology, Arthroscopy
Published in: Knee Surgery, Sports Traumatology, Arthroscopy 5/2009

01-05-2009 | Editorial

Do not use bisphosphonates without scientific evidence, neither in treatment nor prophylactic, in the treatment of stress fractures

Author: Ingrid Ekenman

Published in: Knee Surgery, Sports Traumatology, Arthroscopy | Issue 5/2009

Login to get access

Excerpt

Stress fractures are common in athletes and can end the career because of its long time for healing [1, 2, 4, 5, 14]. In military recruits, especially in basic training, it has led to modification of the type of training, the time for the repetitions and the load [9, 10]. The researchers are trying hard to get a solution to the problem, not only with different types of surgery but also by medical treatment [4, 11]. …
Literature
1.
Bennell KL, Malcolm SA, Brukner PD, Green RM, Hopper JL, Wark JD, Ebeling PR (1998) A 12-month prospective study of the relationship between stress fractures and bone turnover in athletes. Calcif Tissue Int 63:80–85PubMedCrossRef
2.
Burr DB, Milgrom C, Boyd RD, Higgins WL, Robin G, Radin EL (1990) Experimental stress fractures of the tibia. Biological and mechanical aetiology in rabbits. J Bone Joint Surg Br 72:370–375PubMed
3.
Burr DB, Forwood MR, Fyhrie DP, Martin RB, Schaffler MB, Turner CH (1997) Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J Bone Miner Res 12:6–15PubMedCrossRef
4.
Burr DB (2001) Pharmaceutical treatments that may prevent or delay the onset of stress fractures. In: Burr DB, Milgrom C (eds) Muscloskeletal fatigue and stress fractures. CRC Press, Boca Raton, pp 259–270
5.
Korpelainen R, Orava S, Karpakka J, Siira P, Hulkko A (2001) Risk factors for recurrent stress fractures in athletes. Am J Sports Med 29:304–310PubMed
6.
Kurth AH, Eberhardt C, Müller S, Steinacker M, Schwarz M, Bauss F (2005) The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats. Bone 37:204–210PubMedCrossRef
7.
Lenart BA, Lorich DG, Lane JM (2008) Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 358:1304–1306PubMedCrossRef
8.
Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB (2001) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28:524–531PubMedCrossRef
9.
Milgrom C, Simkin A, Eldad A, Nyska M, Finestone A (2000) Using bone’s adaptation ability to lower the incidence of stress fractures. Am J Sports Med 28:245–251PubMed
10.
Milgrom C, Finestone A, Sharkey N, Hamel A, Mandes V, Burr D, Arndt A, Ekenman I (2002) Metatarsal strains are sufficient to cause fatigue fracture during cyclic overloading. Foot Ankle Int 23:230–235PubMed
11.
Milgrom C, Finestone A, Novack V, Pereg D, Goldich Y, Kreiss Y, Zimlichman E, Kaufman S, Liebergall M, Burr D (2004) The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits. Bone 35:418–424PubMedCrossRef
12.
Miltner O, Niedhart C, Piroth W, Weber M, Siebert CH (2003) Transient osteoporosis of the navicular bone in a runner. Arch Orthop Trauma Surg 123:505–508PubMedCrossRef
13.
Ott SM (2001) Fractures after long-term alendronate therapy. J Clin Endocrinol Metab 86:1835–1836PubMedCrossRef
14.
Pepper M, Akuthota V, McCarty EC (2006) The pathophysiology of stress fractures. Clin Sports Med 25:1–16PubMedCrossRef
15.
Ringe JD, Body JJ (2007) A review of bone pain relief with ibandronate and other bisphosphonates in disorders of increased bone turnover. Clin Exp Rheumatol 25:766–774PubMed
16.
Taki M, Iwata O, Shiono M, Kimura M, Takagishi K (2007) Extracorporeal shock wave therapy for resistant stress fracture in athletes: a report of 5 cases. Am J Sports Med 35:1188–1192PubMedCrossRef
17.
Wysowski DK, Chang J (2005) Alendronate and risedronate: reports of severe bone, joint, and muscle pain. Arch Intern Med 165:346–347PubMedCrossRef
Metadata
Title
Do not use bisphosphonates without scientific evidence, neither in treatment nor prophylactic, in the treatment of stress fractures
Author
Ingrid Ekenman
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Knee Surgery, Sports Traumatology, Arthroscopy / Issue 5/2009
Print ISSN: 0942-2056
Electronic ISSN: 1433-7347
DOI
https://doi.org/10.1007/s00167-009-0742-z

Other articles of this Issue 5/2009

Knee Surgery, Sports Traumatology, Arthroscopy 5/2009 Go to the issue

Shoulder

Gender-specific Constant score correction for age

Knee

The femoral sulcus in total knee arthroplasty

Knee

Functional outcomes and health-related quality of life after robot-assisted anterior cruciate ligament reconstruction with patellar tendon grafts

Knee

Validity and responsiveness of the test of athletes with knee injuries: the new criterion based functional performance test instrument

Knee

Measurement of joint gap load in patella everted and reset position during total knee arthroplasty

Letter to the Editor

Is the central portal a safe approach for arthroscopy of the knee?